Comerica Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Comerica Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,815	Closed	-$462K	–	501
2021 Q4	$462K	Buy	2,815 +154	+6%	+$24.9K	0.03%	337
2021 Q3	$442K	Buy	+2,661	New	+$455K	0.03%	332
2021 Q2	–	Sell	-2,841	Closed	-$456K	–	486
2021 Q1	$456K	Sell	2,841 -79	-3%	-$13.5K	0.03%	333
2020 Q4	$491K	Buy	2,920 +246	+9%	+$39.9K	0.04%	298
2020 Q3	$421K	Buy	2,674 +36	+1%	+$5.88K	0.04%	304
2020 Q2	$443K	Buy	+2,638	New	+$414K	0.04%	288
2019 Q2	–	Sell	-1,396	Closed	-$211K	–	418
2019 Q1	$211K	Buy	+1,396	New	+$201K	0.02%	400
2018 Q4	–	Sell	-1,487	Closed	-$236K	–	414
2018 Q3	$236K	Hold	1,487	–	–	0.03%	385
2018 Q2	$208K	Buy	+1,487	New	+$204K	0.03%	391

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Comerica Securities's FBT Position: Q1 2022 in Review

Comerica Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 2,815 shares — an estimated $462K sold.

Comerica Securities first reported a position in FBT in Q2 2018 and held it in 9 quarters. The position peaked at $491K in Q4 2020. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

Comerica Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
Comerica Securities sold 2,815 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $462K.
Comerica Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 9 quarters.
Comerica Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $491K in Q4 2020.
220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Comerica Securities's 13F filing for Q1 2022, filed 28 Apr 2022.